Active Ingredient: IBUPROFEN LYSINE
Proprietary Name: IBUPROFEN LYSINE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A202402
Product Number: 001
Approval Date: Mar 30, 2016
Applicant Holder Full Name: XGEN PHARMACEUTICALS DJB INC
Marketing Status:
Prescription
Patent and Exclusivity Information
